跳至主要内容
临床试验/NCT04050124
NCT04050124已完成不适用

Impact of Promogran Prisma™ on Pain of Split-thickness Skin Graft Donor Sites Compared to Standard of Care Alone

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2019年11月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
1
主要终点
Pain Score on Visual Analogue Scale (VAS)

研究概览

简要总结

The purpose of this study is to assess the feasibility of evaluating the use of a composite collagen, silver-oxidized regenerated cellulose matrix compared to the standard of care dressing on donor site pain for patients undergoing split-thickness skin grafting in preparation for a larger study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient scheduled to undergo STSG for any reason
  • Patient, or designated healthcare proxy, has read and signed the IRB-approved informed consent form.

排除标准

  • Active infection or history of radiation to the donor site
  • Patient has a known sensitivity to Promogran Prisma™ or silver
  • Elevated INR >3.0
  • Insensate at the donor site
  • Chronic narcotic use (>6 months of daily use)

结局指标

主要结局

Pain Score on Visual Analogue Scale (VAS)

时间窗: Postoperative Day 1

Pain score is measured using a VAS ranging from 0-10, where 0 = no pain and 10 = unbearable pain. Participants select the number that best reflects their current status. The total score is the numerical response; lower scores indicate lower pain.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验